Victoria, Canada

Jàn Burian

This inventor holds 1 USPTO granted patent. Top assignee: Migenix, Inc.. Active years: 2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jàn Burian. Retrieved from https://idiyas.com/inventor/jàn-burian

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jàn Burian: Innovator in Antimicrobial Peptide Production

Introduction

Jàn Burian is a notable inventor based in Victoria, Canada. He has made significant contributions to the field of biotechnology, particularly in the production of antimicrobial peptides. His work focuses on developing efficient methods for producing these peptides, which are crucial for therapeutic applications.

Latest Patents

Jàn Burian holds a patent for "Efficient methods for producing anti-microbial cationic peptides in host cells." This patent addresses the challenges associated with the cost of producing cationic antimicrobial peptides, which are vital components of host defenses in various organisms. The methods described in his patent enable the efficient production of these peptides from recombinant host cells. Additionally, the recombinantly-produced cationic peptides can be rapidly purified from host cell proteins using anion exchange chromatography.

Career Highlights

Jàn Burian is associated with Migenix, Inc., where he applies his expertise in biotechnology to advance the field of antimicrobial therapies. His innovative approaches have the potential to enhance the effectiveness and affordability of peptide-based treatments.

Collaborations

Jàn collaborates with Daniel Bartfeld, contributing to the development of new technologies and methodologies in the field of antimicrobial research.

Conclusion

Jàn Burian's work in the production of antimicrobial peptides represents a significant advancement in biotechnology. His innovative methods have the potential to improve therapeutic applications and make peptide production more efficient.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…